Astellas Pharma Inc. (ALPMY)
OTC: ALPMY
· Real-Time Price · USD
9.64
-0.15 (-1.53%)
At close: Jun 13, 2025, 3:59 PM
Astellas Pharma Revenue
Astellas Pharma reported an annual revenue of $1,603.7B, reflecting a 5.6% growth. For the quarter ending June 30, 2024, Astellas Pharma generated $473.12B in revenue.
Revenue (ttm)
$1,603.7B
Revenue Growth
5.6%
Price / Sales Ratio
1.83
Revenue / Employee
$108.69M
Employees
14,754
Market Cap
17.35B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|